about
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.Substance P-mediated chemokine production promotes monocyte migration.Sustained Low Serum Substance P Levels in Non-Surviving Septic Patients.Antiallodynic Effects of Bee Venom in an Animal Model of Complex Regional Pain Syndrome Type 1 (CRPS-I).Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults.Aspects of Corneal Transplant Immunology.Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.When Clarity Is Crucial: Regulating Ocular Surface Immunity.A Chitosan-Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide.In Situ Bone Tissue Engineering With an Endogenous Stem Cell Mobilizer and Osteoinductive Nanofibrous Polymeric Scaffolds.Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage.Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.Capsaicin pretreatment reversed pulmonary arterial hypertension by alleviating inflammation via p38MAPK pathway.Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality.The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension
P2860
Q38622923-905473AB-6331-4682-A083-792EAB55C280Q40268840-DCF0DEDC-B5BA-4F51-B085-5E1547DEB32EQ41182975-41D406B7-5CB7-4BFB-B86C-E56595A374FEQ41669213-F0DB4831-A299-4E8A-BBCF-720EEE2019DFQ41924104-00F772FB-EB5E-434A-B36D-FD5EC86C4132Q42336546-16CA4B0A-429C-4679-BE64-B773DBD10156Q47277890-DC2605B5-B058-4831-A6C0-C0A6A5D2F8EAQ47297420-AC0CE470-4A53-4FE3-AB11-6015B18FD6ACQ47324350-BD39A917-71AA-4DC0-A1A8-B944BF3B44ECQ47660637-8051EEA1-C0DD-493D-9F49-B21806679B32Q48358527-C233FEAB-6234-44A3-A2A6-1402DA7C2338Q49972918-AB442670-CD5D-484E-953F-0A9F2C3B98D8Q51102739-39F5FFBF-9065-4BB9-AFC3-E3D4B344F8DFQ55003470-5CCE9937-AFC6-4E5E-8532-77EEC926CE3CQ57167791-5C04D72B-5B2C-4B8E-8EB8-DE28CEDA3BDC
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neuropeptide substance P and the immune response.
@en
type
label
Neuropeptide substance P and the immune response.
@en
prefLabel
Neuropeptide substance P and the immune response.
@en
P2093
P2860
P1476
Neuropeptide substance P and the immune response.
@en
P2093
Anna Marmalidou
Charalabos Pothoulakis
Mohsen Tehrani
P2860
P2888
P304
P356
10.1007/S00018-016-2293-Z
P577
2016-06-17T00:00:00Z